no significant effect of IL-2 was noted. Among the different proteins that were found to be upregulated by IL-15, one was identified by microsequencing as the cytoskeletal protein actin. Finally, we found that IL-15 delays apoptosis of neutrophils more efficiently than IL-2 when evaluated by both microscopic observations and flow cytometry procedures. Furthermore, this phenomenon was dose-dependent ( I O to 500 nglmL), and, at 500 ng/mL, IL-15 delayed apoptosis as strongly as granulocyte-macrophage colonystimulating factor. This study is the first to show that IL-15 is a significant neutrophil agonist. Moreover, in view of the differential effects of IL-15 and IL-2 on this cell type, our results support the existence of a specific IL-15R componentls) on human neutrophils. 0 1996 by The American Society of Hematology.
We also analyzed the effects of 1L-15 on apoptosis because the regulation of apoptosis in neutrophils by proinflammatory stimuli is an area of study that has just recently been the subject of investigation and could significantly influence how we view the role of these cells in host defense responses. Finally, we considered it important to fully characterize the effects of IL-15 on neutrophils because this cytokine is likely to be used as a therapy for cancer in humans.""' Furthermore, IL-15 was found to use the yL chain to mediate its effects. It has recently been shown that mutations in this chain are associated with X-linked severe combined immunodeficiency.'4"7 Therefore, the discovery of the presence of this chain on human neutrophils makes the present study relevant and of potential importance for future work on this important clinical entity.
MATERIALS AND METHODS
Neutrophil isolation and incubation conditions. Cells were isolated from venous blood of healthy volunteers by centrifugation over Ficoll-Hypaque (Pharmacia Biotech Inc, Quebec, Canada), as previously described.",""" All cell suspensions contained fewer than 1 % monocytes as determined by monoesterase staining. Cell viability, as monitored by the ability to exclude Trypan blue, was greater than 95% immediately after isolation as well as after 4 and 24 hours of incubation in the presence or absence of agonists. If not specified, for all experiments. neutrophils were resuspended in RPM1 supplemented with I % human autologous serum.
Agonisrs. Purified recombinant human L 1 5 (specific activity, 2.4 X lo5 UIpg) and recombinant human IL-4 were provided by Immunex Corp (Seattle, WA). Recombinant human [L-2 (specific activity, 22 X IOh U/mg) was provided by Cetus Corp (Emeryville, CA), whereas recombinant human granulocyte-macrophage colonystimulating factor (GM-CSF; specific activity of 9 X 10' U/mg) was a gift from the Genetics Institute (Boston, MA).
All of the above recombinant forms of cytokines will be hereafter referred to as IL-15, IL-2, IL-4, or GM-CSF. Based on previous published results, IL-2 was used at 45.5 nglmL, which is equivalent to 1,ooO U/mL, the amount used to induce some neutrophil responses.'"' GM-CSF was used at 65 nglmL, which is equivalent to 3 nmol/L, the concentration known to be optimal.q~'x~'O Microscopic observations of human neutrophils. Cells ( 5 X IO" cells/mI,) were incubated at 37°C in 5% CO2 in 96-well plates for up to 24 hours in the presence of buffer, GM-CSF (65 ng/mL), L-15 (1 to 1, OOO ng/mL), or L -2 (1-4500 ng/mL). Morphological changes of cells were observed under light microscopy (magnification, X 200). and micrographs were taken after 3 hours (optimal conditions) using Kodak Tmax 100 ASA film (Eastman-Kodak, Rochester, NY) for black and white prints.
Phagocytosis of sheep erythrocytes. Sheep erythrocytes were opsonized with a final U200 dilution of rabbit IgG antisheep erythrocyte antibody (Sigma Chemical CO, St Louis, MO) by an incubation of 45 minutes at 37°C as previously described.% Neutrophils (2.5 X IO6 cells) pretreated for 15 minutes with buffer, L -2 (45.5 ng/mL), IL-15 (10 ng/mL), or IL-4 (10 ng/mL) were incubated with 50 X lo6 opsonized sheep erythrocytes for 45 minutes, as above. The samples were centrifuged 200g at 4°C for 10 minutes. Supernatants were discarded, and an osmotic shock was performed with the pellets by treating them with 500 pL HzO for 15 seconds followed immediately by the addition of 10 mL ice-cold Hanks' balanced salt solution (HBSS). The samples were washed twice with ice-cold HBSS, and the final pellets were suspended in 1 mL HBSS. Duplicate cytocentrifuge preparations were prepared with aliquots of ~2 0 0 pL and were processed for measuring apoptosis as described below. Phagocytic activity was measured as the percentage of neutrophils ingesting opsonized sheep erythocyte~.'~ Superoxide production. The superoxide production was monitored by the (superoxide dismutase-sensitive) reduction of cytochrome c as previously rep~rted.'~.'~ Briefly, neutrophil suspensions (1 X IO6 celYmL) were incubated with 130 pmoVL cytochrome c (Sigma) for 5 or 30 minutes at 37°C in the presence or absence of IL-15 (10 or 500 ng/mL) or phorbol myristate acetate (PMA; mol/L), the latter being used as a positive c o n t r~l .~~.~~ Reactions were stopped by transfemng the tubes to an ice-cold bath. The absorption of cytochrome c was monitored at 550 and 540 nm, and the amount of superoxide anions produced was calculated from the difference between the optical density at the two wavelengths, using an extinction coefficient of 2 1. I .25. 26 RNA synthesis assay. This assay was performed by measuring the incorporation of [5-3H]-uridine (obtained from Amersham Corp [Oakville, Ontario, Canada]) into total RNA essentially as previously described'."? 100 pL of a 5 X IO6 cells/mL suspension was incubated in 96-well microtiter plates in the presence of 1 pCi of [3H]-uridine along with agonists for 4 hours (previously shown to be optimal) at 37°C in 5% CO,. After incubation, the cells were collected onto borosilicate glass fiber paper by a multiple-cell culture harvester (Skatron Instruments Inc, Sterling, VA), and sections of the filter corresponding to each microwell were then punched out and placed in scintillation-counting vials in the presence of 4 mL of Aquasol-2 (Dupont-NEN, Boston, MA). The results were expressed as stimulation indices representing the ratio of counts per minute (cpm) obtained with stimulated over unstimulated neutrophils from several different normal subjects, as indicated in the figure legends. All experiments were performed in triplicate.
Metabolic labeling of neutrophils, protein precipitation, and 2-dimensional (2-D) gel electrophoresis. Metabolic labeling of neutrophils (200 pL of 50 X lo6 cells/mL) was performed with [35S] methionine and [35S] cysteine (both used at 125 pCi/107 cells; Amersham), as previously in the presence of protease inhibitors (60 trypsin-inhibiting U/mL aprotinin, 1 mmol/L phenylmethyl sulfonyl fluoride, 0.5 pg/mL leupeptin, and 200 pmol/L EDTA). Protein precipitation was performed in Eppendorf tubes, with a final concentration of 70% ethanol, and cells were treated for 1 hour at -20°C. After centrifugation, the pellet was solubilized with the lysis buffer (9.5 m o m urea, 2% NP-40, and 5% 8-mercaptoethanol), and 10 pL of each corresponding fraction was loaded in scintillation-counting vials with 4 mL of Aquasol-2 to determine the amount of radiolabeled proteins loaded for the migration. Highresolution 2-D gel electrophoresis was performed using intracellular neutrophil proteins (from a final number of cells of 5 X lo6) according to the method of 0~~~1 1~~ using the Millipore Investigator 2D Electrophoresis System (Millipore Corp, Bedford, MA). Firstdimension isoelectric focusing was performed using 2% ampholite (1:4 [voVvol] ; pH range, 4 to 8 and 3 to 10). Gels for the second dimension were 12% acrylamide. The gels were dried and exposed for 3 to 5 days at -70°C.
Microsequencing. After 2-D gel electrophoresis, proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore Corp). Two major spots were detected with Coomassie-blue staining of membranes. They were excised and microsequenced with an Applied Biosystems gas phase sequencer model 475A with online FTH analysis and data collection (Applied Biosystems, Foster City, CA). All the chemicals and protocols used were those recommended by the manufacturer.
Assessment of neutrophil apoptosis by cytology and b y f i w cytometry. Cytocentrifuge preparations of neutrophils were performed as previously described using a Cyto-tek centrifuge (Miles Scientific, Naperville, FL)." Cells were incubated in the presence or absence of L-15, L-2, or GM-CSF for 24 hours in RPMI-1640-10% autologous serum and were stained with Diff-Quick stain set (Baxter, Miami, FL) according to the manufacturer's instructions. Cells were examined by light microscopy (final magnification, X m), and apoptotic neutrophils were defined as cells containing one or more characteristic darkly stained pyknotic nuclei.'' An ocular containing a 10 X 10 square grill was used to count at least five different fields (>500 cells in total) for assessment of apoptotic cells. Results were expressed as percentage of apoptotic cells. We also evaluated apoptotic neutrophils by flow cytometry according to differences in their stainability with propidium iodide (PI) and Hoechst (HO), essentially as previously described." Cells were incubated as above, and, after the 24 hours of incubation, an aliquot of 350 pL of each cell suspension (representing -2.5 X IO6 cells, after 24 hours) was washed twice with neutral phosphate-buffered saline followed by an addition of 100 pL of PI (from a 20-pg/mL solution) for 30 minutes on ice that was light-protected. Cells were then treated with 950 pL of 25% ethanol and 50 pL of H033342 (from a Il2-pg/mL solution) and were kept on ice for 12 hours before performing fluorescenceactivated cell sorting (l0,OOO events) analysis using an EPIC 753 (Coulter, Miami Lakes, FL).
RESULTS

IL-15 induces neutrophil morphological changes.
In previous studies, we observed that GM-CSF, IL-13, and IL-4, but not IL-2, induce morphological changes of human neutrophils in vitro that are typical of activated cells.'' In the present report, we investigated whether IL-15 can induce such a response and compared it with that of IL-2 and GM-CSF. Figure l shows that cells incubated with IL-2 (500 ng/ mL; Fig 1B) remained with a round shape, much like that of control cells (Fig lA) , whereas the shape of cells incubated with E-15 (500 ng/mL; Fig 1C) was altered and was comparable with cells activated with GM-CSF (65 ng/mL; Fig 1D) . This assay was performed with 10 different donors, and the results were highly reproducible. In previous studies, we had used amounts as high as 4,500 nglmL of IL-2 and still had observed no effect (data not shown).
IL-15 induces phagocytosis. We next investigated the effect of E-15 and IL-2 on inducing phagocytosis, knowing that it was previously reported that IL-2 had no effect on neutrophil phagocyt~sis.~' IL-4 was used as a positive control because it was shown to increase neutrophil phagocyt~sis.~' was significantly increased by IL-4 (n = 4) and IL-IS (n = 6). whereas this increase was not observed with IL-2 (each cytokine was used at 10 ng/mL). The number of erythrocytes ingested per 100 neutrophils was also scored and less than S 8 of cells presented two or more erythrocytes per cell whether or not they were treated with cytokines. We then decided to verify potential dose-response effects of IL-I S ( 10 to S00 ng/mL) on phagocytosis. The results shown in Fig 3 show that IL-IS increases phagocytosis in a dose-dependent fashion.
IL-I5 docs not mohrlote respiratot? burst. Superoxide production is a well known classical function of neutroand, because of the absence of information on the effect of IL-IS on this function, we decided to study both the direct effect of IL-IS on superoxide production as well as its potential role in priming the response to the chemoattractant formyl-methionyl-leucyl-phenylalanine (FMLP) peptide. We used IL-IS at two different concentrations (10 and S00 ng/mL). We found that IL-IS, similar to IL-2, does not modulate directly superoxide production, a feature previously reported by and others'' with other cytokines of the IL family. After S minutes of stimulation, we observed that superoxide production (mean SEM of three different neutrophil donors) from cells incubated with buffer. IL-15 (10 ng/mL). IL-2 (10 ng/mL), or PMA ( IO" mol/L), was 0.6 2 0.06, 0.5 2 0.001, 0.7 t 0.003, 13.0 2 1.4 nmol/lOh cells, respectively. PMA was used here as a positive After 30 minutes of stimulation, we observed that superoxide production was less than 1 nmoVl0" cells whether neutrophils were incubated in the presence or phils,?5.'6.>?->J absence of IL-IS or IL-2 (data not shown). whereas we observed that superoxide production from PMA-treated cells was 42.6 2 S (n = 3). The results obtained with SO0 ng/mL were similar to those obtained with 10 ng/mL (data not shown). We then tested whether IL-IS can prime the response to FMLP. In these experiments, cells were preincubated for 30 minutes with buffer, IL-IS (S00 ng/mL), IL-2 (S00 ng/mL), or GM-CSF (65 ng/mL: used as a positive control)".'" followed by stimulation with FMLP (3 X 10"" mol/L) for S minutes. Whereas the superoxide production was 8.9 2 2.0 nmol/106 cells when neutrophils were preincubated with GM-CSF. we observed that it was 1.9 t 0.39, 1.9 2 0.30. and 2.2 2 0.20 nmoVl0" cells for control, IL-IS-. and IL-2-treated cells. respectively (n = 3).
IL-15 irlrreosc~s de trove RNA spntllcsi.~. To investigate the effect of IL-IS on the initiation of gene expression in neutrophils, we measured [>H]-uridine uptake into total RNA. We had previously shown that IL-2 ( 1 to 4.500 ng/mL) does not significantly increase de novo RNA synthesis.".'x In the present study, we used the same methodology and observed that. after 4 hours of incubation, IL-IS. unlike IL-2.
increases de novo RNA synthesis (Fig 4) . The synthesis of RNA induced by IL-I S was abolished (up to 9S% inhibition) in the presence of the transcription inhibitor actinomycin D. by 2-D gel electrophoresis and fluorography. Before loading the gels, the radiolabeled proteins were precipitated, and total counts (cpm X 1,000) from an equal number of cells were measured in a scintillation counter. The counts were 415.6 ? 14.7, 435.0 ? 15.7, and 499.0 +-25.0 cpm for control cells, IL-2-, and IL-15-treated cells, respectively (n = 3). This result shows clearly that IL-15 significantly (P < .05, by Student's t-test) increases de novo synthesis of proteins more efficiently than IL-2. The fluorographs shown in Fig 5 are representative results obtained from five different donors and were performed with an equal number of cells (final number, 5 X lo6 cells). Clearly, this cytokine was capable of strongly inducing the synthesis of at least five different proteins or sets of proteins (identified by boxes) and, to a lesser degree, six other proteins (identified by numbers). No significant effect of IL-2 was observed because gels were comparable with those of control cells (Fig 5A) . However, the synthesis of other proteins appeared to be inhibited by IL-15, and these are identified by parenthesis (Fig   5) .
Identijkation of actin as an [L-15-inducedprotein. Coomassie-blue staining of the gels showed a major spot at the 42-kD molecular weight marker and a PI level of 5.4 (spot no. 2). This protein was processed for microsequencing. After performing 29 cycles in the sequencer with this protein, we observed a perfect match (100% homology) with the human protein actin. According to the l-letter amino acid code, the sequence was as follows:
This sequence corresponds to amino acids 44 + 72 of the human actin protein and is common to both nonmuscle 0 and y isoforms."."' The synthesis of actin in control cells was comparable with that of IL-2 (see arrow in Fig SA and B) .
IL-15 delays apoptosis more efficiently than IL-2. IL-2 has been described as a cytokine that can prevent apoptosis of human neutrophils when used at 1 . O O O U/mL (which corresponds in this study to 45.5 n~/ m L ) .~~ Therefore, we decided to study the effect of IL-IS on apoptosis. Figure 6 shows that IL-IS. in contrast to 1L-2, significantly decreases the number of apoptotic cells (35.3% 2 5.1% [ P < .OS] U 45.5% 2 9.2% [ P = 33533, respectively) when compared with that for control cells (57.8% t 7.3%). Because it had previously been shown that GM-CSF strongly delays neutrophil apoptosis,'x we used it in our study as a positive control. After 24 hours of incubation, we observed up to 75% inhibition of apoptosis with GM-CSF when compared with that for control cells. We further investigated the effect of IL-15 and IL-2 on neutrophil apoptosis by performing assays with increasing concentrations of both IL-2 and IL-15 (from 10 to SO0 ng/mL). We observed that IL-IS delays apoptosis in a concentration-dependent fashion, and, when using 500 ng/ mL of IL-I S, neutrophil apoptosis was delayed as strongly as it was with GM-CSF, whereas no such effect was obtained with IL-2 (Fig 7) .
We next evaluated apoptosis by flow cytometry to confirm our microscopic observations. Previous experiments (performed to verify the efficacity of this technique in our hands) indicated that, after 24 hours of incubation, 43.8% 2 3.9% of control cells were in apoptosis versus 17.4% -t 2.3% for GM-CSF-treated cells (n = S; P = ,0004; data not shown). The results obtained by the flow cytometry procedure from two donors (Fig 8A) show that IL-15 (SO0 ng/mL), but not 1L-2, delays neutrophil apoptosis as strongly as GM-CSF. Figure 8B shows the corresponding results obtained by the cytospin preparations from the same two donors, which indicate that the microscopic observation of one or more characteristic darkly stained pyknotic nuclei observed in apoptotic neutrophils correlates well with the decrease in DNA staining by H0 reagent.
DISCUSSION
It is generally accepted that neutrophils play roles in host responses that extend well beyond their capacities to function as phagocytes and cell-releasing cytotoxic compounds. In particular, they are considered to be capable of synthesizing de novo, host defense proteins such as cytokines that have the potential to perform active functions in the afferent and efferent limbs of the immune re~ponse.".~" It is also clear that ILs and other proinflammatory stimuli are capable of modulating a number of neutrophil responses, including apoptosis. Before the present report, little information was available on the effects of the recently discovered IL-IS molecule on neutrophil functions. This area of study seemed promising given the knowledge that this cytokine mediates its effects through interactions with the IL-2RO and IL-2Ry. Both of these components were recently shown to be present on human neutrophils.'"' It seemed also relevant to study potential differences in effects between IL-2 and IL-IS, because both cytokines were recently shown to use different a chains in addition to the IL-2RB and IL-2Ry components in mice.' The human IL-2Ra chain is known to be absent on neutrophils7." and seems to be ~ninducible.~ It remains to be determined whether the human equivalent to the murine 1L-1Sa chain is present on neutrophils.
In this study, our first observation was that IL-IS induces Results are the mean ? SEM from three different donors, and performed in duplicate. Unlike 11-2, a doseresponse effect was obtained when using IL-15 (from 10 t o 500 n g l mL). For simplicity, only the results obtained with 500 nglmL of IL-2 are shown. GM-CSF was also used herein as a control. Ctrl, control cells; *, P < .05 by Student's t-test.
cell shape changes in neutrophils that are typical of activated cells. whereas IL-2 exerts no such effects even when used in very high amounts. The cell shape changes induced by IL-15 were observed when using as little as 10 ng/mL and were highly comparable with those observed with GM-CSF at higher concentrations ( I 00 to S00 ng/mL). At this early stage of our studies, this tinding appeared to be a clear indication that IL-IS can interact with neutrophils and is capable of initiating the cellular events that are needed for cytoskeleton rearrangement.
We next investigated the effects of this cytokine on the induction of phagocytosis.
Similar to others, we had previously observed that IL-2 had no effect on the phagocytic activity of neutrophils'" but had confirmed the previously reported observation that IL-4 is a modulator of phagocytos k 3 ' Using IL-2 and IL-4 as negative and positive controls, respectively, we were able to show clearly that IL-IS must now be recognized as an IL capable of increasing phagocytic activity in neutrophils. Others had previously shown that neutrophil chemotaxis is not induced by IL-IS, and we did not repeat these studies. However, we extended our study to examine the potential effects of IL-IS on the respiratory burst response and found no effect. At this point, we were led to conclude that, although IL-15 appears to be a significant neutrophil agonist in vitro, its effects are selective, dissimilar to those of molecules such as GM-CSF and FLMP (which induce a wider range of responses in neutrophils) but more similar to those of IL-4 and IL-13 (Girard et al'x,").
The results of previous studies from our laboratory had also shown that. although neutrophils are terminally differentiated cells, they are still capable of undergoing active gene transcription and de novo protein synthesis.'~'x~'"~4' Furthermore, we reported that these activities may be modulated by a selective group of proinflammatory molecules.*' However, at that time, IL-15 was not available for study. Therefore, we were interested in investigating the effects of IL-15 on both de novo RNA and protein synthesis, knowing that IL-2 had no significant effect. However, we also knew that another receptor-related cytokine, IL-4, was capable of modulating these activities? Both de novo RNA and protein synthesis were found to be initiated by IL-15. Induction of RNA synthesis was inhibited by actinomycin D, showing that the assay we used reflected transcriptional effects of IL-15, and total count measurements as well as 2-D gel analysis of cell lysates showed significant induction of protein synthesis by IL-15. This was not the case with IL-2 because results of 2-D gel analysis were comparable with those obtained with control cells (Fig 5) . Although five proteins or sets of proteins (identified by boxes) were markedly induced by IL-15, successful identification of the nature of these proteins was not made because all were found to be blocked at the N-terminal and, therefore, were unfit for microsequencing. Experiments are ongoing to prepare protease-digested fragments of these proteins, a procedure that should circumvent this difficulty. However, one protein, which was not N-terminally blocked, (spot no. 2) and the synthesis of which was induced by IL-15, was identified as actin. Actin is a cytoskeleta1 protein known to play a major role in the basic functions in cell motility, phagocytosis, cell permeability, movement of organelles, anchorage of many surface receptors, signal transduction, cell-cell interactions, and mRNA localization between induction of actin synthesis and cytoskeleton rearrangement by IL-13,'* IL-4, and a selective group of cytokines (D. Girard, unpublished observations). Finally, when studying the potential modulatory effects of IL-15 on neutrophil apoptosis, we found that IL-2 has little effect in delaying apoptosis, whereas IL-15 has a marked effect. In a single recent report, 1L-2 was shown to significantly prevent human neutrophil apoptosis." This discrepancy of results with IL-2 may be explained, in part, by experimental culture conditions. We used fresh, daily tion. 35 .36 Recently, we have been able to show a close correlaprepared human autologous serum (10%) instead of the commercially available human AB serum (5%). Furthermore, it has recently been shown that the number of cells undergoing apoptosis may vary according to the cell concentration This may also explain our differences of results with IL-2, because we cultured neutrophils at 10 X lo6 celis/mL instead of 2 X lo6 cells/mL. It is of particular interest that, when IL-15 was used at higher concentrations, it was found to delay apoptosis as strongly as GM-CSF. Results were confirmed using two different methods of measurement (Fig  8) .
It is well accepted that a cytokine may exert biological functions on various cell types and that different cytokines can exert common biological functions on the same cell type. Such an observation is known as the concept of pleiotropy and redundancy of ~y t o k i n e s~~,~ and may be explained by the recent finding of the presence of a common receptor component such as y c , which is shared by receptors for IL-2, IL-4, IL-7, IL-9, and, more recently, IL-15.'0.".'4.'5.'7.43-47 Before our present study, many investigators were unable to clearly identify any major differences of biological activity between IL-2 and IL-15 on various cell type^.^.^ Although we cannot deny the concept of pleiotropy and redundancy of cytokines, in this report, using neutrophils as a target for IL-15, we clearly showed that IL-15 can exert distinct biological actions when compared with those of IL-2. This indicates that biological activities of IL-15 are not totally redundant to those of IL-2.
In light of the results of the present study, which is the first in-depth analysis on the effects of IL-15 on human neutrophils, we propose that IL-15 is likely to be a significant neutrophil agonist in vivo and that close monitoring of neutrophil functions will need to be made when using IL-15 as a therapeutic agent in humans.
